These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 30763

  • 1. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [Abstract] [Full Text] [Related]

  • 2. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [Abstract] [Full Text] [Related]

  • 3. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 5. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [Abstract] [Full Text] [Related]

  • 6. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL, Parmley LF.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [Abstract] [Full Text] [Related]

  • 7. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L, Schatzberg AF.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [Abstract] [Full Text] [Related]

  • 8. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG.
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK.
    Psychopharmacol Bull; 1993 Jan; 29(2):303-8. PubMed ID: 7904761
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Jan; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 11. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP, Fanielle J, Mormont C, Breulet M, Bobon J.
    Acta Psychiatr Belg; 1978 Jan; 78(4):619-34. PubMed ID: 31063
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern ME, Micallef J, Blin O.
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM, Brion S, Escande M, Ropert R, Sacquepee L, Singer L, Scotto JC.
    Encephale; 1984 Apr; 10(3):135-8. PubMed ID: 6389091
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC, O'Hair DE.
    Clin Ther; 1980 Apr; 3(3):209-18. PubMed ID: 6109568
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW, Bystritsky A.
    J Clin Psychiatry; 1997 Apr; 58 Suppl 11():24-9. PubMed ID: 9363045
    [Abstract] [Full Text] [Related]

  • 16. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB, Ballenger JC, Rickels K.
    J Clin Psychiatry; 1997 Apr; 58 Suppl 11():11-8. PubMed ID: 9363043
    [Abstract] [Full Text] [Related]

  • 17. Lorazepam in the treatment of neurosis.
    Lameiras JC.
    Curr Med Res Opin; 1976 Apr; 4(6):441-5. PubMed ID: 11961
    [Abstract] [Full Text] [Related]

  • 18. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V, Maffei F, Montanaro N, Morandini G.
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [Abstract] [Full Text] [Related]

  • 19. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW, Daniel JT, King RE, Moore DT.
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [Abstract] [Full Text] [Related]

  • 20. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB.
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.